Earnings Call · Q4 FY2022·2023-02-28

Q4 22EPS +20.00%·Rev n/aQ3 22EPS +33.33%·Rev n/aQ2 22EPS -25.00%·Rev n/aQ1 22EPS -100.00%*·Rev n/a⚠ consensus missing

Cytek Biosciences, Inc. CTKB

Paul Goodson — Host/Moderator

Wenbin Jiang — Chief Executive Officer

Patrik Jeanmonod — Chief Financial Officer

−7.9%1d on move date−7.5% vs SPY3d+3.0%5d−2.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CTKB calls or request research access.

More CTKB calls Browse calls Request research access